Experimental limb transplantation, Part II: Excellent return of function and indefinite survival after withdrawal of immunosuppression

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 675-679

  Lanzetta, M ^a,b,c   Ayrout, C ^a   Gal, A ^a   Dereli, Z ^a   Wright, B ^a   Lauer, C ^a   Owen, E R ^a  

^a Microsearch Foundation of Australia   (Australia)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIMB TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HINDLIMB; HYPEREMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MODELS, ANIMAL; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED BN; RATS, INBRED F344; TRANSPLANTATION, HOMOLOGOUS;

EID: 2042509698     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.03.008     Document Type: Conference Paper

References (15)

1. Dubemard J.M., Owen E.R., Herzberg G., et al. Human hand allograft report on first 6 months. Lancet. 353:1999;1315
2. Dubemard J.M., Owen E.R., Lanzetta M., et al. What is happening with hand transplants? Lancet. 357:2001;1711
3. Lanzetta M., Nolli R., Borgonovo A., et al. Hand transplantation immunosuppression, ethics and indications. Journal of Hand Surgery (B). 26:(B):2001;511
4. Arai K., Hotokebuchi T., Miyamara H., et al. Limb allografts in rats immunosuppressed with FK506. Transplantation. 48:1989;782
5. Zoller K.M., Cho S.I., Cohen J.J., et al. Cessation of immunosuppressive therapy after successful transplantation a national survey. Kidney International. 18:1980;11
6. Starzl T.E., Demetris A.J., Trucco M., et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation. 55:1993;1272
7. Hotokebuchi T., Arai K., Takagishi K., et al. Limb allografts in rats immunosuppresed with cyclosporine as a whole joint allograft. Plast Reconstr Surg. 83:1989;1027
8. Min Z., Jones N.F. Limb transplantation in rats Immunosuppression with FK506. Journal of Hand Surgery. 20A:1995;77
9. Jones N.F., Hebebrand D., Buttemeyer R., et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tecrolimus and mycophenolate mofetil implications for clinical composite tissue transplantation. Plast Reconstr Surg. 107:2001;777
10. Benhaim P., Anthony J.P., Ferreira L., et al. Use of combination of low-dose cyclosporine and RS61443 in a rat hindlimb model of composite tissue allotransplantation. Transplantation. 61:1996;527
11. Khanna A.K. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation. 70:2000;690
12. Foster R.D., Fan L., Niepp M., et al. Donor-specific tolerance induction in composite tissue allografts. Am J Surg. 176:1998;418
13. Hewitt C.W. Update and outline of the experimental problems facing clinical composite tissue transplantation. Transplant Proc. 30:1998;2704
14. Kuroki H., Bean M.A., Ikuta Y., et al. Synergistic effect ofFK506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Transplant Proc. 23:1991;3282
15. Yu X.Z., Carpenter P., Anasetti C. Advances in transplantation tolerance. Lancet. 357:2001;1959